Advanced Glycation End Products and Oxidative Stress in Type 2 Diabetes Mellitus

被引:798
|
作者
Nowotny, Kerstin [1 ]
Jung, Tobias [1 ]
Hoehn, Annika [1 ]
Weber, Daniela [1 ]
Grune, Tilman [1 ]
机构
[1] German Inst Human Nutr Potsdam Rehbrucke, Dept Mol Toxicol, Arthur Scheunert Allee 114-116, D-14558 Nuthetal, Germany
来源
BIOMOLECULES | 2015年 / 5卷 / 01期
关键词
advanced glycation end products; oxidative stress; type 2 diabetes mellitus; insulin resistance; cell dysfunction; diabetic complications;
D O I
10.3390/biom5010194
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Type 2 diabetes mellitus (T2DM) is a very complex and multifactorial metabolic disease characterized by insulin resistance and cell failure leading to elevated blood glucose levels. Hyperglycemia is suggested to be the main cause of diabetic complications, which not only decrease life quality and expectancy, but are also becoming a problem regarding the financial burden for health care systems. Therefore, and to counteract the continually increasing prevalence of diabetes, understanding the pathogenesis, the main risk factors, and the underlying molecular mechanisms may establish a basis for prevention and therapy. In this regard, research was performed revealing further evidence that oxidative stress has an important role in hyperglycemia-induced tissue injury as well as in early events relevant for the development of T2DM. The formation of advanced glycation end products (AGEs), a group of modified proteins and/or lipids with damaging potential, is one contributing factor. On the one hand it has been reported that AGEs increase reactive oxygen species formation and impair antioxidant systems, on the other hand the formation of some AGEs is induced per se under oxidative conditions. Thus, AGEs contribute at least partly to chronic stress conditions in diabetes. As AGEs are not only formed endogenously, but also derive from exogenous sources, i.e., food, they have been assumed as risk factors for T2DM. However, the role of AGEs in the pathogenesis of T2DM and diabetic complicationsif they are causal or simply an effectis only partly understood. This review will highlight the involvement of AGEs in the development and progression of T2DM and their role in diabetic complications.
引用
收藏
页码:194 / 222
页数:29
相关论文
共 50 条
  • [41] Advanced glycation end-products and advanced oxidation protein products in patients with diabetes mellitus
    Kalousová, M
    Skrha, J
    Zima, T
    PHYSIOLOGICAL RESEARCH, 2002, 51 (06) : 597 - 604
  • [42] Association between serum levels of soluble receptor for advanced glycation end products and circulating advanced glycation end products in type 2 diabetes
    K. C. B. Tan
    S. W. M. Shiu
    W. S. Chow
    L. Leng
    R. Bucala
    D. J. Betteridge
    Diabetologia, 2006, 49 : 2756 - 2762
  • [43] Association between serum levels of soluble receptor for advanced glycation end products and circulating advanced glycation end products in type 2 diabetes
    Tan, K. C. B.
    Shiu, S. W. M.
    Chow, W. S.
    Leng, L.
    Bucala, R.
    Betteridge, D. J.
    DIABETOLOGIA, 2006, 49 (11) : 2756 - 2762
  • [44] Studies of advanced glycation end products and oxidation biomarkers for type 2 diabetes
    Chiu, Chung-Jung
    Rabbani, Naila
    Rowan, Sheldon
    Chang, Min-Lee
    Sawyer, Sherilyn
    Hu, Frank B.
    Willett, Walter
    Thornalley, Paul J.
    Anwar, Attia
    Bar, Liliana
    Kang, Jae H.
    Taylor, Allen
    BIOFACTORS, 2018, 44 (03) : 281 - 288
  • [45] Advanced glycation end products and their receptors in serum of patients with type 2 diabetes
    Diana Indyk
    Agnieszka Bronowicka-Szydełko
    Andrzej Gamian
    Aleksandra Kuzan
    Scientific Reports, 11
  • [46] Advanced glycation end products and their receptors in serum of patients with type 2 diabetes
    Indyk, Diana
    Bronowicka-Szydelko, Agnieszka
    Gamian, Andrzej
    Kuzan, Aleksandra
    SCIENTIFIC REPORTS, 2021, 11 (01)
  • [47] Role of advanced glycation end products with oxidative stress in resistance artery dysfunction in type 2 diabetic mice
    Su, Jun
    Lucchesi, Pamela A.
    Gonzalez-Villalobos, Romer A.
    Palen, Desiree I.
    Rezk, Bashir M.
    Suzuki, Yasuhiro
    Boulares, Hamid A.
    Matrougui, Khalid
    ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 2008, 28 (08) : 1432 - 1438
  • [48] Advanced Glycation End Products (AGEs), Oxidative Stress and Diabetic Retinopathy
    Yamagishi, Sho-ichi
    Matsui, Takanori
    CURRENT PHARMACEUTICAL BIOTECHNOLOGY, 2011, 12 (03) : 362 - 368
  • [49] Influence of Oxidative Stress on the Formation of Advanced Glycation End-Products
    Breyer, Viola
    Pischetsrieder, Monika
    FREE RADICAL BIOLOGY AND MEDICINE, 2009, 47 : S118 - S119
  • [50] Oxidative Stress and Advanced Glycation End Products in Hashimoto's Thyroiditis
    Ruggeri, Rosaria M.
    Vicchio, Teresa M.
    Cristani, Mariateresa
    Certo, Rosaria
    Caccamo, Daniela
    Alibrandi, Angela
    Giovinazzo, Salvatore
    Saija, Antonina
    Campenni, Alfredo
    Trimarchi, Francesco
    Gangemi, Sebastiano
    THYROID, 2016, 26 (04) : 504 - 511